Galapagos Financial Statements From 2010 to 2024
| GLPG Stock | EUR 25.70 0.20 0.78% |
Check Galapagos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Galapagos' main balance sheet or income statement drivers, such as , as well as many indicators such as . Galapagos financial statements analysis is a perfect complement when working with Galapagos Valuation or Volatility modules.
Galapagos |
Galapagos NV Company Profit Margin Analysis
Galapagos' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Galapagos Profit Margin | 0.01 % |
Most of Galapagos' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galapagos NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Galapagos NV has a Profit Margin of 0.0096%. This is 100.09% lower than that of the Biotechnology sector and 100.04% lower than that of the Health Care industry. The profit margin for all Netherlands stocks is 100.76% lower than that of the firm.
Galapagos NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Galapagos's current stock value. Our valuation model uses many indicators to compare Galapagos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Galapagos competition to find correlations between indicators driving Galapagos's intrinsic value. More Info.Galapagos NV is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Galapagos' earnings, one of the primary drivers of an investment's value.About Galapagos Financial Statements
Galapagos shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Galapagos investors may analyze each financial statement separately, they are all interrelated. The changes in Galapagos' assets and liabilities, for example, are also reflected in the revenues and expenses on on Galapagos' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium. GALAPAGOS operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 1397 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Galapagos Stock Analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.